Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021

NCT07302607 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT07302607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07302607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021
Lead sponsor
University Hospital, Strasbourg, France
Phase
Observational
Overall status
Recruiting
Start date
December 11, 2024
Completion date
January 31, 2026
Enrollment
221 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii melanoma